The independent source for health policy research, polling, and news.
181 - 200 of 380 Results
A few hundred hospitals have banded together to sue drugmakers in state courts, but far more are staying on the sidelines to avoid 'unflattering attention' about their role in the opioid crisis.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you dont have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you dont have to.
The topic, which polls show is top of mind among voters, kept returning throughout the fourth debate of Democratic presidential candidates.
The Democratic presidential candidates have hit hard on health care, but generally the debates have centered on what kind of system candidates propose. The candidates ideas on many other issues, such as mental health and gun safety, have attracted much less attention.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Naltrexone, commonly used for opioid and alcohol use disorders, may also help patients with chronic pain when prescribed in low doses. But few doctors or patients seem to know about it.
Programs for health care professionals addicted to opioids generally bar a proven recovery method: the use of drugs like buprenorphine and methadone to relieve cravings.
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
An average of three people a day died of opioid overdose in Philadelphia in 2018. But efforts to combat the crisis with a supervised injection site could be stymied by the crackhouse statute, a portion of federal law meant to protect neighborhoods during the crack epidemic of the 1980s.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
KHN's Sarah Varney discussed opioid painkillers in India with NPR's Rachel Martin on "Morning Edition" Thursday.
President Donald Trump keeps promising a new health plan, but so far its nowhere to be seen. Meanwhile, Democratic presidential candidate Sen. Bernie Sanders (I-Vt.) is proposing a plan to cancel billions of dollars in medical debt owed by patients. This week, Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Kimberly Leonard of the Washington Examiner join KHNs Julie Rovner to discuss these issues and more. Rovner also interviews KHNs Rachel Bluth about the latest Bill of the Month feature. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
As schools begin a new year, more districts will test students as young as 11 for illicit drug use even as other drug prevention efforts are scaled back. More than 1 in 3 school districts nationwide give students drug tests.
New research published in JAMA Network Open quantified for the first time international differences in doctors prescribing habits and patients use of these highly addictive painkillers.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients pain, the nations sprawling, cash-fed health care system is ripe for misuse.
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
穢 2026 KFF